XENE compared with CRNX: revenue, margins and what each company keeps, and the suppliers and customers both name

XENEXenon Pharmaceuticals Inc.

Mkt capRevenueRevenue

CRNXCrinetics Pharmaceuticals, Inc.

Mkt capRevenueRevenue

Compare

XENEXenon Pharmaceuticals Inc.

CRNXCrinetics Pharmaceuticals, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Co-movers

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Co-movers

daily closesMethod ›

Moved together

XENEwithCRNX

Uncorrelated: r 0.24 · 460D.

Shared co-movers3with XENEwith CRNX

XNCRXencor Incr 0.38r 0.33

IDYAIDEAYA Biosciences, Inc.r 0.42r 0.30

DYNDyne Therapeutics, Inc.r 0.40r 0.29

XENE, solidCRNX, hatchedr = correlationBar = r to r 0.75Order: weaker of A and BSource: daily closes

XENEXenon Pharmaceuticals Inc.

37.69▼−3.84%· post 37.69· delayed

Mkt cap$3.8BRevenue$8MQ1 FY25Revenue—

CRNXCrinetics Pharmaceuticals, Inc.

84.97▲+0.15%· post 84.97· delayed

After hoursNov 5 '26delayed

Mkt cap$509.7MRevenue$25MQ2 FY26Revenue$8MFY25

Compare

After hoursNov 5 '26delayed

XENEXenon Pharmaceuticals Inc.

CRNXCrinetics Pharmaceuticals, Inc.

37.69▼−3.84%post 37.69delayed

Price

84.97▲+0.15%post 84.97delayed

$3.8B

Mkt cap

$509.7M

Q1 FY25$8M

Revenue

$25MQ2 FY26

—

Revenue

$8MFY25

XENE37.69▼−3.84%vsCRNX84.97▲+0.15%After hoursNov 5 '26delayed